Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
CVS Health
CVS
CVS Health
Why CVS’s Valuation Signals Opportunity
YI
yiannisz
Invested
Community Contributor
Published
28 Oct 24
Updated
30 Oct 24
99
Set Fair Value
13
votes
9
Share
yiannisz
's Fair Value
US$103.00
30.8% undervalued
intrinsic discount
30 Oct
US$71.30
Loading
1Y
21.5%
7D
1.6%
Author's Valuation
US$103.0
30.8% undervalued
intrinsic discount
yiannisz's Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
yiannisz
's
Fair Value
US$103.0
30.8% undervalued
intrinsic discount
Future estimation in
5 Years
time period
Past
Future
0
829b
2013
2016
2019
2022
2024
2025
2028
2029
Revenue US$828.5b
Earnings US$16.5b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
4.72%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.17%
Calculation
US$16.46b
Earnings '29
x
9.88x
PE Ratio '29
=
US$162.71b
Market Cap '29
US$162.71b
Market Cap '29
/
1.12b
No. shares '29
=
US$144.91
Share Price '29
US$144.91
Share Price '29
Discounted to 2024 @ 6.86% p.a.
=
US$104.01
Fair Value '24
